What are the potential complications of taking 100 mg of aspirin (acetylsalicylic acid) daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Complications of 100 mg of Aspirin

Daily aspirin at 100 mg significantly increases the risk of gastrointestinal bleeding, with approximately 1 in 248 users developing GI bleeding per year, even at this relatively low dose. 1

Gastrointestinal Complications

Bleeding Risk

  • Even at doses as low as 75-100 mg/day, aspirin doubles the risk of upper gastrointestinal bleeding compared to non-users 1
  • The absolute risk of GI bleeding with low-dose aspirin is estimated at:
    • 1 in 248 subjects per year 1
    • 5 cases per 1000 aspirin users per year of symptomatic or complicated ulcers 2
    • Potentially life-threatening bleeding events occur at a rate of approximately 1% per year (1 per 100 patient years) 1

Endoscopic Findings

  • Asymptomatic mucosal damage is common:
    • Nearly 48% of asymptomatic patients taking low-dose aspirin (100-325 mg) for more than 3 months show ulcers or erosions on endoscopy 3
    • Erosive gastroduodenitis, gastric ulcers, and duodenal ulcers are the most common findings 3

Risk Factors for Increased GI Complications

The risk of GI complications with 100 mg aspirin increases substantially with:

  • Age > 70 years (doubles the risk) 1, 4, 5
  • History of peptic ulcer disease or previous GI bleeding 4, 5
  • Concomitant use of other medications:
    • NSAIDs (quadruples the risk compared to aspirin alone) 1, 5
    • Anticoagulants 1, 4
    • Other antiplatelet drugs 4, 5
  • H. pylori infection 4, 6
  • Alcohol consumption 4
  • Multiple comorbidities 4, 5

Other Complications

Hemorrhagic Stroke

  • Low-dose aspirin is associated with a slight increase in hemorrhagic stroke risk 1
  • In primary prevention settings, this risk may offset some of the benefits in patients with low cardiovascular risk 1

Lower GI Tract Damage

  • Evidence indicates that low-dose aspirin can damage the lower GI tract as well, though the magnitude of this problem is less well-defined 2

Prevention of Complications

For patients requiring aspirin therapy who are at high risk for GI complications:

  1. Use the lowest effective dose (75-100 mg daily) 1, 4
  2. Consider proton pump inhibitors (PPIs) as first-line therapy for high-risk patients:
    • PPIs reduce the risk of gastric and duodenal ulcers by up to 90% 4
    • Superior to H2-receptor antagonists for prevention of aspirin-related ulcers 4
  3. For patients with history of ulcer bleeding, the combination of aspirin plus PPI is superior to switching to clopidogrel alone 4
  4. Test for and treat H. pylori infection in patients with history of peptic ulcer disease 4, 5

Common Pitfalls in Managing Aspirin-Related GI Risk

  • Assuming absence of symptoms means absence of risk - most patients who develop serious aspirin-related GI complications have no prior warning symptoms 4
  • Ignoring drug interactions, especially combinations with NSAIDs, anticoagulants, or corticosteroids 4
  • Poor adherence to prescribed gastroprotective agents 4
  • Overlooking H. pylori status 4, 6

Benefit-Risk Assessment

The decision to use 100 mg aspirin should carefully weigh benefits against risks:

  • For secondary prevention of cardiovascular events (after stroke or MI), the benefits generally outweigh the risks 1
  • For primary prevention, the benefit-risk balance is less favorable, especially in those at low cardiovascular risk 1
  • The European Society of Cardiology and American College of Chest Physicians recommend using the lowest effective dose (75-100 mg daily) for cardiovascular protection 1, 4

Remember that GI risk with aspirin is continuous while taking the medication and doesn't diminish with time 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Gastrointestinal lesions and complications of low-dose aspirin in the gastrointestinal tract.

Best practice & research. Clinical gastroenterology, 2012

Research

Endoscopy in asymptomatic minidose aspirin consumers.

Digestive diseases and sciences, 2005

Guideline

Aspirin Therapy and Gastric Risk Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Risk factors for gastrointestinal bleeding associated with low-dose aspirin.

Best practice & research. Clinical gastroenterology, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.